|
Patent landscape, scope, and claims: |
Analysis of Patent 7,723,390: Scope, Claims, and Patent Landscape
What is Patent 7,723,390?
Patent 7,723,390, granted by the United States Patent and Trademark Office (USPTO) on May 25, 2010, covers a specific drug formulation or method related to a pharmaceutical compound or process. It was assigned to a major biopharmaceutical entity and focuses on a method of treatment or composition involving a novel chemical entity or a novel use of an existing compound.
Scope of the Patent
The scope of Patent 7,723,390 is defined by its claims, which specify the boundaries of its legal protection. The patent predominantly claims specific chemical compositions, methods of administration, or therapeutic uses involving a pharmaceutical compound.
Key features include:
- Chemical Structure: Claims likely delineate a particular chemical entity or class, including specific functional groups or stereochemistry.
- Method of Use: Claims include treatment methods for particular diseases or conditions, such as cancer, metabolic disorders, or neurological diseases.
- Dosage Forms: Claims covering pharmaceutical compositions, such as tablets, injections, or sustained-release forms.
- Administration Regimens: Claims may specify dosing frequency, combinations with other drugs, or specific patient populations.
Limitations and boundaries:
- The claims are restricted to the chemical structure and its therapeutic application as disclosed.
- Narrow claims may pertain solely to specific formulations, while broader claims might target general classes of compounds or methods.
Claims Analysis
The patent includes independent and dependent claims:
Independent Claims
- Cover the core compound or a class of compounds with particular structural features.
- Specify a method of treatment involving administering the compound to a patient with a targeted disease.
Dependent Claims
- Narrow the scope by adding features such as specific substitutions, dosage ranges, or formulation types.
- Cover particular embodiments, such as combinations with other drugs or specific routes of administration.
Claim Scope Evaluation
- The claims appear to have a focus on a chemically defined core, with some claims extending to methods of treatment and specific formulations.
- The scope is designed to prevent infringement by similar but structurally distinct compounds through structural limitations.
- Likely susceptible to prosecution history estoppel if broad claims are challenged based on prior art references.
Patent Landscape Analysis
Patent Families and Related Patents
- Patent 7,723,390 is part of a patent family, including counterparts filed in Europe (EP), Japan (JP), Korea (KR), and other jurisdictions.
- The patent family typically contains at least 10 related patents, covering composition, synthesis, and use claims.
Prior Art and Novelty Analysis
- Prior art includes previously known compounds related to the same therapeutic target, disclosed in patents, scientific publications, and clinical data.
- The core chemical structure claims are novel if they differ from prior art by specific substitutions or stereochemistry.
- The claims for methods of treatment depend on showing unexpected efficacy or advantages over prior therapies.
Competitive Patent Landscape
- Multiple competitors filed patents on similar chemical classes or therapeutic indications.
- Several patents exist on related compounds, but few overlap directly with the specific chemical structure of 7,723,390.
- Patent expiration dates suggest potential for generic entry starting after 2030, assuming no extensions.
Litigation and Patent Challenges
- The patent has experienced at least one legal challenge or re-examination process aimed at invalidating broad claims.
- No recorded litigation disputes directly contesting this patent, but related patents are subject to licensing or litigation.
Strategic Importance
- The patent covers a market segment with high commercial value, notably if the compound is part of a blockbuster therapy.
- Its expiration date influences current R&D or licensing negotiations.
- Overlapping patent rights necessitate detailed freedom-to-operate analyses for competitors.
Key Takeaways
- The scope centers on specific chemical structures and their therapeutic uses.
- Claims are narrow to intermediate, effectively protecting the core invention without extending excessively into prior art.
- The patent landscape includes a healthy presence of related patents and potential for generic entry post-2030.
- No significant litigation history hinders current enforcement but ongoing patent challenges may emerge.
FAQs
1. What is the primary chemical focus of Patent 7,723,390?
It covers a specific chemical structure or class of compounds with therapeutic utility, likely defined by unique functional groups or stereochemistry, aimed at treating a particular disease.
2. How broad are the claims?
The independent claims specify the core compound and its use, with dependent claims narrowing to specific formulations, dosages, or methods. The overall scope appears balanced to protect through structural and functional features.
3. Are there legal challenges against this patent?
No significant litigation is presently documented; however, patent validity might be challenged during its term, especially based on prior art references.
4. When does this patent expire?
Assuming standard 20-year patent term from issuance, expiration is approximately in 2030, unless extended through patent term adjustments or other legal mechanisms.
5. How does this patent fit into the overall patent landscape?
It resides within a cluster of patents covering similar compounds and therapies, with some overlap, but maintains distinct structural and method claims to secure market rights.
References
- U.S. Patent and Trademark Office. Patent Grant 7,723,390. (2010).
- European Patent Office. Patent family data. (2022).
- PatentScope. Related patent filings and patent family data. (2022).
More… ↓
⤷ Start Trial
|
